Archive for August, 2025

image_pdf

Antitrust Life Sciences Quarterly Update 2025 Q2

The first half of 2025 has seen an acceleration of M&A activity, including large-scale life sciences transactions, such as Merck’s $3.9 billion acquisition of SpringWorks, Sanofi’s $9.5 billion acquisition of Blueprint Medicines, and Johnson & Johnson’s $14.6 billion acquisition of Intra-Cellular Therapies, as well as notable developments in litigation and…

Read More

Move Fast: FDA is Accepting Submissions for the Pilot Program Class for FDA Commissioner’s National Priority Voucher Program

FDA is now accepting submissions to the Commissioner’s National Priority Voucher (CNPV) pilot program, and with only five vouchers to be awarded as part of the initial year of the program, the competition is anticipated to be fierce. It has been a little over a month since the FDA announced the CNPV…

Read More